• Consensus Rating: Buy
  • Consensus Price Target: $69.00
  • Forecasted Upside: 20.73 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$57.15
▼ -0.06 (-0.10%)

This chart shows the closing price for CTVA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Corteva Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTVA

Analyst Price Target is $69.00
▲ +20.73% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Corteva in the last 3 months. The average price target is $69.00, with a high forecast of $75.00 and a low forecast of $58.00. The average price target represents a 20.73% upside from the last price of $57.15.

This chart shows the closing price for CTVA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 16 contributing investment analysts is to buy stock in Corteva. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 13 buy ratings
  • 4 hold ratings
  • 3 sell ratings
4/9/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 3 sell ratings
7/8/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 3 sell ratings
10/6/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/4/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/4/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/3/2022
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/1/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/1/2022

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/22/2022UBS GroupBoost TargetBuy$66.00 ➝ $70.00Low
9/15/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$68.00 ➝ $75.00Low
9/14/2022BMO Capital MarketsBoost TargetOutperform$66.00 ➝ $72.00Low
9/14/2022KeyCorpBoost TargetOverweight$64.00 ➝ $72.00Low
8/9/2022Credit Suisse GroupBoost Target$72.00N/A
8/9/2022Royal Bank of CanadaBoost TargetOutperform$67.00 ➝ $72.00Low
8/8/2022MizuhoBoost TargetBuy$68.00 ➝ $69.00Low
8/8/2022CitigroupBoost TargetBuy$63.00 ➝ $69.00Low
8/8/2022Deutsche Bank AktiengesellschaftLower Target$72.00 ➝ $68.00Low
8/8/2022Roth CapitalUpgradeNeutral ➝ Buy$67.00 ➝ $74.00Low
8/8/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$58.00 ➝ $63.00Low
7/14/2022Credit Suisse GroupInitiated CoverageOutperform$68.00Low
7/13/2022UBS GroupLower Target$68.00 ➝ $64.00Low
6/1/2022BarclaysInitiated CoverageOverweight$71.00Low
5/31/2022Deutsche Bank AktiengesellschaftBoost Target$64.00 ➝ $72.00Medium
5/23/2022ArgusBoost TargetBuy$61.00 ➝ $69.00Low
5/10/2022Deutsche Bank AktiengesellschaftBoost Target$56.00 ➝ $64.00Medium
5/6/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$58.00High
4/29/2022MizuhoBoost Target$60.00 ➝ $67.00Low
4/14/2022Vertical ResearchDowngradeBuy ➝ Hold$58.00Low
4/14/2022Loop CapitalUpgradeHold ➝ Buy$69.00Low
4/5/2022KeyCorpBoost TargetOverweight$58.00 ➝ $63.00Low
3/22/2022CitigroupBoost TargetBuy$59.00 ➝ $66.00Medium
2/4/2022KeyCorpBoost TargetOverweight$55.00 ➝ $58.00High
2/4/2022MizuhoBoost Target$55.00 ➝ $60.00High
1/31/2022Redburn PartnersUpgradeNeutral ➝ BuyLow
1/11/2022CitigroupBoost Target$55.00 ➝ $57.00Medium
11/15/2021Morgan StanleyBoost TargetOverweight$55.00 ➝ $60.00High
11/5/2021KeyCorpBoost TargetOverweight$53.00 ➝ $55.00Low
10/18/2021Loop CapitalDowngradeBuy ➝ HoldHigh
10/12/2021MizuhoInitiated CoverageBuy$53.00Medium
10/8/2021Roth CapitalInitiated CoverageBuy$53.00Low
9/1/2021Berenberg BankInitiated CoverageBuy$58.00Medium
8/9/2021BarclaysLower TargetEqual Weight$53.00 ➝ $51.00Low
8/9/2021Royal Bank of CanadaBoost TargetOutperform$52.00 ➝ $54.00Low
8/9/2021Monness Crespi & HardtUpgradeSell ➝ NeutralLow
5/17/2021ArgusBoost TargetBuy$51.00 ➝ $54.00Low
5/10/2021Bank of AmericaDowngradeBuy ➝ Underperform$50.00 ➝ $42.00High
5/10/2021Morgan StanleyBoost TargetOverweight$50.00 ➝ $55.00High
5/6/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$50.00 ➝ $55.00Low
4/19/2021Loop CapitalUpgradeHold ➝ Buy$54.00Low
4/12/2021KeyCorpBoost TargetOverweight$51.00 ➝ $53.00Low
2/5/2021Credit Suisse GroupBoost TargetNeutral$39.00 ➝ $42.00Low
2/5/2021Morgan StanleyBoost TargetOverweight$46.00 ➝ $50.00Medium
2/5/2021Monness Crespi & HardtBoost TargetSell$24.00 ➝ $32.00High
2/5/2021KeyCorpBoost TargetOverweight$49.00 ➝ $51.00High
2/5/2021Royal Bank of CanadaBoost TargetOutperform$45.00 ➝ $52.00Medium
2/5/2021BarclaysBoost TargetEqual Weight$37.00 ➝ $46.00Medium
2/5/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$32.00 ➝ $51.00Medium
2/4/2021UBS GroupBoost TargetBuy$44.00 ➝ $48.00Low
1/21/2021Redburn PartnersDowngradeBuy ➝ NeutralHigh
1/15/2021KeyCorpBoost TargetOverweight$40.00 ➝ $49.00Low
1/8/2021Deutsche Bank AktiengesellschaftBoost TargetOutperform ➝ Buy$40.00 ➝ $50.00High
12/18/2020Susquehanna BancsharesDowngradePositive ➝ NeutralHigh
12/14/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$35.00 ➝ $46.00Low
11/16/2020Royal Bank of CanadaBoost Target$37.00 ➝ $39.00Low
11/10/2020ArgusUpgradeHold ➝ Buy$42.00High
11/9/2020Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $35.00Low
11/9/2020KeyCorpBoost TargetOverweight$36.00 ➝ $40.00Low
11/6/2020Deutsche Bank AktiengesellschaftBoost Target$32.00 ➝ $40.00Low
11/6/2020Credit Suisse GroupBoost TargetNeutral$28.00 ➝ $34.00Low
11/6/2020BMO Capital MarketsBoost TargetOutperform$36.00 ➝ $38.00Low
10/19/2020Exane BNP ParibasDowngradeOutperform ➝ UnderperformLow
10/19/2020Bank of AmericaUpgradeNeutral ➝ Buy$40.00High
10/19/2020BNP ParibasDowngradeOutperform ➝ UnderperformHigh
10/7/2020KeyCorpBoost TargetOverweight$31.00 ➝ $36.00Medium
8/18/2020Loop CapitalLower TargetHold$32.00 ➝ $30.00Medium
8/11/2020KeyCorpUpgradeSector Weight ➝ Overweight$31.00High
8/10/2020Bank of AmericaDowngradeBuy ➝ Neutral$32.00 ➝ $28.00Low
8/7/2020Credit Suisse GroupLower TargetNeutral$31.00 ➝ $28.00Low
7/13/2020Bank of AmericaUpgradeUnderperform ➝ BuyHigh
6/16/2020Vertical ResearchUpgradeHold ➝ Buy$31.00Medium
6/8/2020Monness Crespi & HardtDowngradeNeutral ➝ Sell$24.00High
6/2/2020Morgan StanleyBoost TargetEqual Weight$27.00 ➝ $29.00High
5/11/2020BarclaysLower TargetEqual Weight$32.00 ➝ $30.00High
5/11/2020Royal Bank of CanadaBoost TargetOutperform$27.00 ➝ $31.00High
5/11/2020Bank of AmericaDowngradeNeutral ➝ UnderperformHigh
5/8/2020Deutsche Bank AktiengesellschaftLower TargetBuy$34.00 ➝ $32.00Low
5/8/2020CitigroupBoost TargetBuy$32.00 ➝ $34.00High
5/5/2020CSFBLower TargetNeutral$31.00 ➝ $28.00Low
5/5/2020Credit Suisse GroupLower TargetNeutral$31.00 ➝ $28.00Medium
4/17/2020Bank of AmericaDowngradeBuy ➝ NeutralMedium
4/17/2020Loop CapitalUpgradeSell ➝ Hold$28.00Medium
4/1/2020BNP ParibasUpgradeNeutral ➝ OutperformHigh
3/31/2020Susquehanna BancsharesUpgradeNeutral ➝ Positive$34.00 ➝ $29.00High
3/30/2020Morgan StanleyLower TargetEqual Weight$30.00 ➝ $27.00Low
3/25/2020KeyCorpInitiated CoverageSector Weight ➝ Sector WeightHigh
3/18/2020Edward JonesUpgradeHold ➝ BuyHigh
3/13/2020Bank of AmericaUpgradeNeutral ➝ BuyHigh
3/10/2020Monness Crespi & HardtUpgradeSell ➝ NeutralHigh
2/4/2020Susquehanna BancsharesDowngradePositive ➝ Neutral$36.00 ➝ $34.00High
2/2/2020Credit Suisse GroupReiterated RatingHold$31.00High
1/31/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$26.00 ➝ $29.00Medium
1/23/2020Bernstein BankUpgradeOutperform$39.00Low
1/23/2020Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$39.00Low
1/23/2020Loop CapitalDowngradeHold ➝ Sell$23.00Low
1/17/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$27.00 ➝ $26.00Medium
12/19/2019Vertical ResearchInitiated CoverageHold$27.00Low
12/19/2019UBS GroupLower TargetBuy$33.00 ➝ $32.00Medium
11/12/2019Redburn PartnersInitiated CoverageBuyHigh
11/1/2019BarclaysSet TargetHold$32.00N/A
11/1/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$30.00 ➝ $27.00Medium
10/11/2019SunTrust BanksLower TargetHold$30.00 ➝ $28.00Low
10/9/2019CitigroupLower TargetBuy$34.50 ➝ $31.00Low
8/19/2019CitigroupUpgradeNeutral ➝ Buy$34.00 ➝ $34.50Low
8/9/2019Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$29.00 ➝ $38.00Low
8/4/2019BarclaysReiterated RatingHold$35.00High
8/2/2019Deutsche Bank AktiengesellschaftBoost TargetBuy$32.00 ➝ $35.00Low
7/17/2019Monness Crespi & HardtInitiated CoverageSell ➝ Sell$24.00High
7/1/2019Loop CapitalInitiated CoverageHold ➝ Hold$31.00Medium
7/1/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$32.00Low
6/21/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$30.00Low
6/20/2019ArgusInitiated CoverageHold ➝ HoldLow
6/20/2019Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$29.00Low
6/16/2019Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$30.00 ➝ $32.00High
6/10/2019Nomura SecuritiesInitiated CoverageNeutral$28.00Low
6/5/2019Sanford C. BernsteinInitiated CoverageMkt Perform ➝ Market Perform$31.00High
6/4/2019MacquarieInitiated CoverageOutperform ➝ OutperformMedium
6/4/2019UBS GroupInitiated CoverageBuy ➝ Buy$38.00High
6/3/2019CitigroupInitiated CoverageNeutral$29.00N/A
6/3/2019SunTrust BanksInitiated CoverageHold ➝ Hold$29.00N/A
6/3/2019Morgan StanleyInitiated CoverageEqual Weight ➝ Equal Weight$32.00N/A
6/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHoldN/A
6/3/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$29.00N/A
6/2/2019BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$37.00N/A
5/29/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyN/A
(Data available from 10/1/2017 forward)

News Sentiment Rating

0.36 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 30 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/5/2022
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/4/2022
  • 2 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/4/2022
  • 5 very positive mentions
  • 36 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
6/3/2022
  • 1 very positive mentions
  • 11 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
7/3/2022
  • 8 very positive mentions
  • 20 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/2/2022
  • 6 very positive mentions
  • 45 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
9/1/2022
  • 11 very positive mentions
  • 40 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
10/1/2022

Current Sentiment

  • 11 very positive mentions
  • 40 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
Corteva logo
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $57.15
Low: $56.39
High: $58.00

50 Day Range

MA: $59.97
Low: $55.22
High: $63.81

52 Week Range

Now: $57.15
Low: $41.37
High: $64.30

Volume

3,688,255 shs

Average Volume

3,318,412 shs

Market Capitalization

$41.36 billion

P/E Ratio

24.11

Dividend Yield

1.05%

Beta

0.68

Frequently Asked Questions

What sell-side analysts currently cover shares of Corteva?

The following Wall Street research analysts have issued research reports on Corteva in the last twelve months: Argus, Barclays PLC, BMO Capital Markets, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., KeyCorp, Loop Capital, Mizuho, Morgan Stanley, Redburn Partners, Roth Capital, Royal Bank of Canada, TheStreet, UBS Group AG, and Vertical Research.
View the latest analyst ratings for CTVA.

What is the current price target for Corteva?

15 Wall Street analysts have set twelve-month price targets for Corteva in the last year. Their average twelve-month price target is $69.00, suggesting a possible upside of 20.7%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting CTVA will reach $75.00 in the next twelve months. Vertical Research has the lowest price target set, forecasting a price of $58.00 for Corteva in the next year.
View the latest price targets for CTVA.

What is the current consensus analyst rating for Corteva?

Corteva currently has 1 hold rating and 15 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CTVA will outperform the market and that investors should add to their positions of Corteva.
View the latest ratings for CTVA.

What other companies compete with Corteva?

How do I contact Corteva's investor relations team?

Corteva's physical mailing address is 974 CENTRE ROAD, WILMINGTON DE, 19805. The company's listed phone number is (833) 267-8382 and its investor relations email address is [email protected] The official website for Corteva is www.corteva.com. Learn More about contacing Corteva investor relations.